Guggenheim Capital LLC Beam Therapeutics Inc. Transaction History

Guggenheim Capital LLC

$12 Billion
Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 35,827 shares of BEAM stock, worth $1.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,827

Previous 42,645 15.99%

Holding current value

$1.09 Million

Previous $1.04 Million 14.94%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$21.55 - $30.35 $146,927 - $206,926	-6,818 Reduced 15.99%	35,827 $888,000
Q3 2024 Nov 13, 2024	SELL	$22.57 - $33.14 $100,075 - $146,942	-4,434 Reduced 9.42%	42,645 $1.04 Million
Q2 2024 Aug 14, 2024	SELL	$21.22 - $32.66 $27,925 - $42,980	-1,316 Reduced 2.72%	47,079 $1.1 Million
Q1 2024 May 14, 2024	SELL	$23.46 - $45.07 $75,259 - $144,584	-3,208 Reduced 6.22%	48,395 $1.6 Million
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $325,319 - $565,676	-18,390 Reduced 26.27%	51,603 $1.4 Million
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $376,190 - $530,688	-16,349 Reduced 18.94%	69,993 $1.68 Million
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $149,649 - $183,692	5,104 Added 6.28%	86,342 $2.76 Million
Q1 2023 May 10, 2023	SELL	$30.15 - $48.79 $199,593 - $322,989	-6,620 Reduced 7.53%	81,238 $2.49 Million
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $12,047 - $16,924	328 Added 0.37%	87,858 $3.44 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $374,384 - $661,546	-9,409 Reduced 9.71%	87,530 $4.17 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $167,305 - $349,403	5,603 Added 6.13%	96,939 $3.75 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $117,238 - $179,273	2,182 Added 2.45%	91,336 $5.23 Million
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $1.15 Million - $1.67 Million	16,846 Added 23.3%	89,154 $7.1 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $4 Million - $6.34 Million	47,463 Added 191.04%	72,308 $6.29 Million
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $1.59 Million - $3.2 Million	24,845 New	24,845 $3.2 Million

Others Institutions Holding BEAM

# of Institutions

253

Shares Held

78.6M

Call Options Held

304K

Put Options Held

142K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.14B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Beam Therapeutics Inc. Transaction History